WIGZELL HANS LENNART RUDOLF sold 41.7% of their position (15K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.60M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/8/2023ACC: 0001209191-23-045095
Director
Since Nov 2018
-15K
Net shares
Net seller
$1.60M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$29.03
Trade value
$435.45K
% of position
71.4%
8/4/2023
20.99K→35.99K
Common Stock
Direct
Shares
−15K
Price / share
$106.72
Trade value
$1.60M
% of position
41.7%
8/4/2023
35.99K→20.99K
Total
Net shares
+0.00
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2023 | M · Option Exercise | +15K | $29.03 | $435.45K | 71.4% | 20.99K | 35.99K |
| Common Stock Direct | 8/4/2023 | S · Sale | −15K | $106.72 | $1.60M | 41.7% | 35.99K | 20.99K |
| Total | +0.00 | -$1.17M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
29.03
Held after
0.00
Exercisable
—
8/4/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15K shares | 8/4/2023 | M · Option Exercise | −15K | 29.03 | — | 0.00 |